These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26940268)

  • 1. B-cell Lymphoproliferative Disorders Associated with Primary and Acquired Immunodeficiency.
    Low LK; Song JY
    Surg Pathol Clin; 2016 Mar; 9(1):55-77. PubMed ID: 26940268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Therapy-associated Lymphoproliferative Disorders: An Under-recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder.
    Pina-Oviedo S; Miranda RN; Medeiros LJ
    Am J Surg Pathol; 2018 Jan; 42(1):116-129. PubMed ID: 29112013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus-associated Lymphoproliferative Disorders in the Skin.
    Goodlad JR
    Surg Pathol Clin; 2017 Jun; 10(2):429-453. PubMed ID: 28477890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between Epstein-Barr virus and lymphoma.
    Bird AG; Britton S
    Semin Hematol; 1982 Oct; 19(4):285-300. PubMed ID: 6297094
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunodeficiency-Associated Lymphoproliferative Disorders.
    Zeppa P; Cozzolino I
    Monogr Clin Cytol; 2018; 23():77-80. PubMed ID: 29131000
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunodeficiency-related Hodgkin lymphoma and its mimics.
    Said JW
    Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.
    Gratzinger D; de Jong D; Jaffe ES; Chadburn A; Chan JK; Goodlad JR; Said J; Natkunam Y
    Am J Clin Pathol; 2017 Feb; 147(2):188-203. PubMed ID: 28395105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome.
    Kingma DW; Mueller BU; Frekko K; Sorbara LR; Wood LV; Katz D; Raffeld M; Jaffe ES
    Arch Pathol Lab Med; 1999 Jan; 123(1):83-7. PubMed ID: 9923843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.
    Eminger LA; Hall LD; Hesterman KS; Heymann WR
    J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 12. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
    Chappuis BB; Müller-Hermelink HK
    Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
    Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
    J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
    Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
    Bienemann K; Borkhardt A; Klapper W; Oschlies I
    Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient.
    Kwon EJ; Katz KA; Draft KS; Seykora JT; Rook AH; Wasik MA; Junkins-Hopkins JM
    J Am Acad Dermatol; 2006 Apr; 54(4):657-63. PubMed ID: 16546589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).
    Chadburn A
    Semin Diagn Pathol; 2013 May; 30(2):113-29. PubMed ID: 23537912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals.
    Purtilo DT; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4209. PubMed ID: 6272963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.